BioMarin’s hemophilia gene therapy recommended for approval in Europe

June 24, 2022

The regulatory agency that recommends whether new drugs should be approved in Europe has thrown its support behind a gene therapy for the rare bleeding disorder hemophilia A, putting the potentially curative treatment one step closer to market. People with […]

Pharmacy chain Walgreens plans to disrupt clinical trial sector

June 17, 2022

The company says it plans to use a “flexible” model, drawing on both decentralised trial (DCT) and conventional site-based models via its Health Corner and Village Medical outlets at various Walgreens locations across the US. The move follows in the […]

Vaccines Don’t Shield Against Long COVID, But May Ease Symptoms

May 25, 2022

Category: Industry, Vaccines

Vaccinated people who experience a breakthrough case of COVID-19 are at risk for developing long-haul symptoms, though they are better protected against some of the worst ones, new data show. Compared to the unvaccinated, people who had COVID shots had […]

Cell and Gene Therapy, Industry

A biotech startup launches with $38M to develop a cystic fibrosis gene therapy

June 21, 2022

Via: Biopharma Dive

Vertex’s latest treatment for cystic fibrosis is a “triple combination” drug called Trikafta, which like others from Vertex boosts the activity of a protein that’s defective in people with the disease. It has quickly become a go-to treatment, entrenching Vertex’s […]

Industry, Vaccines

EMA Starts Rolling Review of Adapted COVID-19 Vaccines

June 21, 2022

Via: Biopharm International

The European Medicines Agency (EMA) has begun a rolling review of the Spikevax vaccine that has been adapted to protect against two variant strains of SARS-CoV-2, the agency announced on June 17, 2022. The review will focus on non-clinical laboratory […]

Industry, Vaccines

With CDC Approval, COVID Shots For Kids Under 5 Ready for Delivery

June 20, 2022


After a final sign-off on Saturday from the head of the U.S. Centers for Disease Control and Prevention, COVID-19 vaccines for children younger than 5 have finally become a reality. “This expands eligibility for vaccination to nearly 20 million additional […]


Pfizer takes stake in French Lyme disease jab partner Valneva

June 20, 2022

Via: Pharmaphorum

The deal gives Valneva a cash injection that it will be able to use to advance Lyme disease candidate VLA15 towards the market, but the revised licensing terms means that the French biotech will shoulder more of the financial cost […]